News

AUSTIN, Texas—Electrophysiologists at the Texas Cardiac Arrhythmia Institute (TCAI) at St. David’s Medical Center have performed 3,000 robotic cardiac ablation procedures, the majority of which treated ventricular tachycardia. The milestone...

 Artificial intelligence can improve diagnosis and treatment for patients, but first the AI-enabled clinical tools have to be easily available and used.

WASHINGTON (Nov 01, 2022) --The American College of Cardiology and Heart Rhythm Society have issued the following statement on the 2023 Medicare Physician Fee Schedule Final Rule: “While the changes the Centers for Medicare and...

Nuevocor, a pre-clinical stage cardiac gene therapy company, announced today that it will present new preclinical data on its adeno-associated virus (AAV) gene therapy for LMNA dilated cardiomyopathy at AHA 2022.

Etripamil, a new chemical entity, is Milestone's lead investigational product.

Knowing BE FAST and calling 911 can prevent a lifetime of disability or death FAIRFAX, Va., Oct. 27, 2022 /-- Ahead of World Stroke Day, Oct. 29, physicians from the Get Ahead of Stroke® campaign are urging the public...

Latest authorization permits the Radiaction Shield System to be used in more labs across the United States

Acute procedural success achieved in all patients using a novel pulsed field ablation (PFA) sine waveform and configurable catheter.

The executive medical director of the Texas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical Center recently led Venice Arrhythmias 2022, a biennial international workshop on cardiac arrhythmias held in Venice, Italy from October 13...